{
    "code": "02025068",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025068",
    "time": "2020-06-19 04:28:04",
    "許可證字號": "衛署藥輸字第025068號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/08\/06",
    "發證日期": "98\/08\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202506802",
    "中文品名": "利福適靜脈注射液",
    "英文品名": "LEVOX IV solution for Infusion",
    "適應症": "治療成人因對Levofloxacin有感受性的致病菌所引起之下列感染：社區性肺炎複雜性泌尿道感染(包括腎盂腎炎)皮膚和軟組織感染",
    "劑型": "270注射劑",
    "包裝": "100毫升玻璃瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LEVOFLOXACIN HEMIHYDRATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201010653  安強藥業股份有限公司",
    "申請商地址": "台北市松山區復興北路311號4樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0135100  Baxter Pharmaceuticals India Private Limited",
            "製造廠廠址": "CHACHARWADI-VASANA, AHMEDABAD-382 213, INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0836002310",
            "成分名稱": "LEVOFLOXACIN HEMIHYDRATE",
            "含量描述": "eq. to Levofloxacin",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Levox仿單1080806TFDA-108-08-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025068&Seq=002&Type=9"
        },
        {
            "title": "利福適標籤圖檔___20120523.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025068&Seq=004&Type=8"
        }
    ]
}